Duff & Phelps Healthcare and Life Sciences team provides Fortune 500 corporations, middle-market and growth companies and financial sponsors access to our valuation and corporate finance services.
Our dedicated team completes nearly 200 healthcare engagements annually, including engagements in healthcare services, Pharmaceuticals, Medical Technology and Life Sciences. As a firm, Duff & Phelps stands alone in our objectivity, deep technical and industry expertise and breadth of advisory services.
Comprehensive support throughout mergers and acquisitions and other corporate transactions.
Healthcare expertise for middle-market M&A transactions.
Fairness and Solvency Opinions
Independent opinions for boards of directors and special committees.
Private Capital Markets
Senior, subordinated and mezzanine debt and venture/private equity for a wide range of transactions.
Transaction Advisory Services
Seamless analytical advisory through the deal continuum, from transaction origination to closing.
Financial Sponsors Group
Dedicated coverage and access to M&A deal-flow for financial sponsors.
Governance, Risk, Investigations and Disputes
Combined Duff & Phelps and Kroll disputes, investigations, cyber, business intelligence, cross-border restructuring and other advisory.
Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.
Innovative tax advisory and compliance services encompassing property tax, sales and use tax, and site selection and incentives.
a portfolio company of
has been acquired by
has entered into an agreement to sell its Life Sciences division to
Duff & Phelps Advised Cristian Lay on its acquisition of Grupo Gallardo to KKR on the standstill agreement between all lenders, assist with cash management, financial due diligence and operational due diligence.
has completed a debt for equity exchange as part of a restructuring transaction
Andrew Probert Discusses COVID-19 Impact on M&A Disputes
Ann Gittleman Quoted in Forbes on Paycheck Protection Fraud
Declan Taite Discusses How Businesses Can Navigate Adversity and Weather the COVID-19 Storm
Gregory Burkart Discusses the ‘Tipping Point’ for Reshoring Production to the U.S.